Biased signaling in GPCRs: Structural insights and implications for drug development
Yuanyuan Ma1, Brandon Patterson1, Lan Zhu1
1Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
Pharmacology & Therapeutics
|December 24, 2024
Summary
Biased agonism offers a new approach to drug discovery by selectively targeting G protein-coupled receptors (GPCRs) to improve efficacy and reduce side effects. Structural insights are key to designing these next-generation biased ligands for better treatments.
Area of Science:
- Pharmacology
- Structural Biology
- Drug Discovery
Background:
- G protein-coupled receptors (GPCRs) are crucial cell surface proteins and major drug targets.
- Traditional drug design often uses uniform agonists/antagonists, but biased agonism offers a refined approach.
- Biased agonism selectively activates specific signaling pathways, promising enhanced therapeutic effects and fewer side effects.
Purpose of the Study:
- To review recent advancements in understanding the mechanisms of biased agonism at GPCRs.
- To highlight the role of structural biology in the rational design of biased ligands.
- To discuss the potential of biased signaling in revolutionizing GPCR-targeted drug discovery.
Main Methods:
- Synthesis of recent findings in GPCR structural biology and biophysics.
- Analysis of techniques for characterizing ligand efficacy and biased signaling.
- Review of drug discovery efforts for biased ligands targeting key GPCRs.
Main Results:
- Advancements in structural biology provide deep insights into GPCR conformational dynamics and ligand interactions.
- Improved methods enable better characterization of biased ligand efficacy.
- Successful development of biased ligands for opioid, angiotensin, and adrenergic receptors demonstrates therapeutic potential.
Conclusions:
- Structural insights are critical for the rational design of biased agonists.
- Biased signaling represents a paradigm shift in GPCR drug development.
- This approach holds the potential for more precise and effective therapeutics.
Related Concept Videos
01:15G Protein-coupled Receptors
11.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.3K
01:22Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
01:12GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
01:30Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
01:21G-protein Coupled Receptors
115.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
115.9K